Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Non-cash Items: 2020-2025

Historic Non-cash Items for Tango Therapeutics (TNGX) over the last 4 years, with Sep 2025 value amounting to $14.7 million.

  • Tango Therapeutics' Non-cash Items rose 39.02% to $14.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.7 million, marking a year-over-year increase of 39.02%. This contributed to the annual value of $11.2 million for FY2024, which is 42.06% up from last year.
  • According to the latest figures from Q3 2025, Tango Therapeutics' Non-cash Items is $14.7 million, which was up 2.87% from $14.3 million recorded in Q2 2025.
  • Tango Therapeutics' Non-cash Items' 5-year high stood at $87.9 billion during Q3 2023, with a 5-year trough of $1.8 million in Q3 2021.
  • For the 3-year period, Tango Therapeutics' Non-cash Items averaged around $8.4 billion, with its median value being $14.3 million (2025).
  • Per our database at Business Quant, Tango Therapeutics' Non-cash Items soared by 2,158,144.54% in 2023 and then slumped by 99.99% in 2024.
  • Tango Therapeutics' Non-cash Items (Quarterly) stood at $51.4 billion in 2021, then tumbled by 52.80% to $24.3 billion in 2022, then crashed by 99.74% to $62.6 million in 2023, then plummeted by 96.56% to $2.2 million in 2024, then surged by 39.02% to $14.7 million in 2025.
  • Its last three reported values are $14.7 million in Q3 2025, $14.3 million for Q2 2025, and $12.9 million during Q1 2025.